TrialDermatology (Basel, Switzerland)2024

Abrocitinib Provides Rapid and Sustained Improvement in Skin Pain and Is Associated with Improved Quality of Life Outcomes in Adult and Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.

Jacob P Thyssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.